NSE BSE
poly medicure limited stock

POLY MEDICURE LIMITED Share Price

- - (%)
Sector: -

25718

531768

POLYMED

img img img img
No Data Available

POLY MEDICURE LIMITED : Share Price Update


As of the latest trading session, POLY MEDICURE LIMITED share price is currently at 1671.25, which is up by 16.55 from its previous closing. Today, the stock has fluctuated between 1639.00 and 1687.55. Over the past year, POLY MEDICURE LIMITED has achieved a return of 69.53 %. In the last month alone, the return has been 5.50 %.

POLY MEDICURE LIMITED Performance

Day Range

Low1639.00 High1687.55
1669.25

52 Week Range

Low 945.00 High 1729.00
1669.25

Open Price

1669.10

Prev. Close

1654.70

Volume (Shares)

20637.00

Total traded value

344.48

Upper Circuit

1985.60

Lower Circuit

1323.80

Note: The current prices & values are delayed, Login to your account for live updates.

POLY MEDICURE LIMITED Fundamentals


(Standalone)

Market Cap (Cr) 16034.70
PE Ratio (TTM) 66.50
Book Value / Share 138.07
Beta 0.43
ROE 15.49%
EPS (TTM) 24.87
Dividend Yield 0.18%
Net Profit Qtr (Cr) 61.46

POLY MEDICURE LIMITED Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars DEC 2023 (Values in Cr)
Revenue 320.86
Operating Expense 255.34
Net Profit 61.46
Net Profit Margin (%) 19.15
Earnings Per Share (EPS) 6.41
EBITDA 100.97
Effective Tax Rate (%) 25.13
Particulars SEP 2023 (Values in Cr)
Revenue 319.90
Operating Expense 254.72
Net Profit 59.21
Net Profit Margin (%) 18.50
Earnings Per Share (EPS) 6.17
EBITDA 95.38
Effective Tax Rate (%) 24.06
Particulars JUN 2023 (Values in Cr)
Revenue 305.56
Operating Expense 237.86
Net Profit 60.52
Net Profit Margin (%) 19.80
Earnings Per Share (EPS) 6.31
EBITDA 98.27
Effective Tax Rate (%) 25.15
Particulars MAR 2023 (Values in Cr)
Revenue 293.31
Operating Expense 228.57
Net Profit 57.48
Net Profit Margin (%) 19.59
Earnings Per Share (EPS) 6.00
EBITDA 90.33
Effective Tax Rate (%) 21.68
Particulars DEC 2022 (Values in Cr)
Revenue 271.74
Operating Expense 221.76
Net Profit 47.54
Net Profit Margin (%) 17.49
Earnings Per Share (EPS) 4.95
EBITDA 82.67
Effective Tax Rate (%) 26.08
Particulars MAR 2023 (Values in Cr)
Revenue 1068.05
Operating Expense 867.50
Net Profit 179.04
Net Profit Margin (%) 16.76
Earnings Per Share (EPS) 18.67
EBITDA 300.77
Effective Tax Rate (%) 24.39
Particulars MAR 2022 (Values in Cr)
Revenue 879.36
Operating Expense 723.37
Net Profit 146.02
Net Profit Margin (%) 16.60
Earnings Per Share (EPS) 15.23
EBITDA 250.87
Effective Tax Rate (%) 25.01
Particulars MAR 2021 (Values in Cr)
Revenue 747.38
Operating Expense 593.29
Net Profit 129.51
Net Profit Margin (%) 17.32
Earnings Per Share (EPS) 14.54
EBITDA 227.60
Effective Tax Rate (%) 25.30
Particulars MAR 2020 (Values in Cr)
Revenue 646.16
Operating Expense 542.96
Net Profit 92.38
Net Profit Margin (%) 14.29
Earnings Per Share (EPS) 10.47
EBITDA 178.72
Effective Tax Rate (%) 24.14
Particulars MAR 2019 (Values in Cr)
Revenue 586.69
Operating Expense 502.03
Net Profit 66.28
Net Profit Margin (%) 11.29
Earnings Per Share (EPS) 7.51
EBITDA 148.14
Effective Tax Rate (%) 34.04
Particulars MAR 2023 (Values in Cr)
Book Value / Share 129.41
ROE % 15.39
ROCE % 18.95
Total Debt to Total Equity 0.12
EBITDA Margin 27.40
Particulars MAR 2022 (Values in Cr)
Book Value / Share 113.40
ROE % 14.27
ROCE % 17.26
Total Debt to Total Equity 0.13
EBITDA Margin 27.66
Particulars MAR 2021 (Values in Cr)
Book Value / Share 100.71
ROE % 19.40
ROCE % 21.67
Total Debt to Total Equity 0.25
EBITDA Margin 30.29
Particulars MAR 2020 (Values in Cr)
Book Value / Share 49.27
ROE % 23.49
ROCE % 24.38
Total Debt to Total Equity 0.45
EBITDA Margin 27.17
Particulars MAR 2019 (Values in Cr)
Book Value / Share 43.22
ROE % 18.18
ROCE % 22.03
Total Debt to Total Equity 0.41
EBITDA Margin 24.70
Particulars MAR 2023 (Values in Cr)
Book Value / Share 128.63
ROE % 15.49
ROCE % 19.21
Total Debt to Total Equity 0.11
EBITDA Margin 28.34
Particulars MAR 2022 (Values in Cr)
Book Value / Share 112.30
ROE % 14.38
ROCE % 17.54
Total Debt to Total Equity 0.12
EBITDA Margin 28.73
Particulars MAR 2021 (Values in Cr)
Book Value / Share 99.50
ROE % 18.72
ROCE % 21.37
Total Debt to Total Equity 0.23
EBITDA Margin 30.73
Particulars MAR 2020 (Values in Cr)
Book Value / Share 48.65
ROE % 22.84
ROCE % 24.24
Total Debt to Total Equity 0.43
EBITDA Margin 27.99
Particulars MAR 2019 (Values in Cr)
Book Value / Share 43.04
ROE % 18.56
ROCE % 22.48
Total Debt to Total Equity 0.39
EBITDA Margin 25.54
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 183.06
Total Assets 1577.20
Total Liabilities 1577.20
Total Equity 1241.62
Share Outstanding 95944342
Price to Book Ratio 7.41
Return on Assets (%) 11.36
Return on Capital (%) 12.92
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 15.43
Total Assets 1376.83
Total Liabilities 1376.83
Total Equity 1087.48
Share Outstanding 95900342
Price to Book Ratio 8.45
Return on Assets (%) 10.64
Return on Capital (%) 12.08
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 29.56
Total Assets 1223.73
Total Liabilities 1223.73
Total Equity 965.57
Share Outstanding 95880567
Price to Book Ratio 8.22
Return on Assets (%) 11.10
Return on Capital (%) 12.36
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 25.35
Total Assets 767.32
Total Liabilities 767.32
Total Equity 434.82
Share Outstanding 88246980
Price to Book Ratio 4.84
Return on Assets (%) 12.49
Return on Capital (%) 15.92
Particulars MAR 2019 (Values in Cr)
Cash & Short Term Investments 54.59
Total Assets 653.95
Total Liabilities 653.95
Total Equity 381.37
Share Outstanding 88236930
Price to Book Ratio 5.04
Return on Assets (%) 10.00
Return on Capital (%) 12.62
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 176.38
Total Assets 1537.76
Total Liabilities 1537.76
Total Equity 1234.12
Share Outstanding 95944342
Price to Book Ratio 7.41
Return on Assets (%) 11.64
Return on Capital (%) 13.08
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 8.31
Total Assets 1333.96
Total Liabilities 1333.96
Total Equity 1076.97
Share Outstanding 95900342
Price to Book Ratio 8.45
Return on Assets (%) 10.94
Return on Capital (%) 12.31
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 27.40
Total Assets 1187.41
Total Liabilities 1187.41
Total Equity 954.00
Share Outstanding 95880567
Price to Book Ratio 8.22
Return on Assets (%) 10.90
Return on Capital (%) 12.03
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 22.39
Total Assets 739.95
Total Liabilities 739.95
Total Equity 429.28
Share Outstanding 88246980
Price to Book Ratio 4.84
Return on Assets (%) 12.48
Return on Capital (%) 15.81
Particulars MAR 2019 (Values in Cr)
Cash & Short Term Investments 53.18
Total Assets 633.15
Total Liabilities 633.15
Total Equity 379.77
Share Outstanding 88236930
Price to Book Ratio 5.04
Return on Assets (%) 10.46
Return on Capital (%) 13.09
Particulars MAR 2023 (Values in Cr)
Net Income 237.49
Cash from Operations 248.69
Cash from Investing -179.01
Cash from Financing -12.50
Net change in Cash -0.69
Free Cash Flow 487.96
Particulars MAR 2022 (Values in Cr)
Net Income 195.24
Cash from Operations 170.92
Cash from Investing -85.33
Cash from Financing -35.33
Net change in Cash 2.80
Free Cash Flow 326.50
Particulars MAR 2021 (Values in Cr)
Net Income 180.05
Cash from Operations 163.35
Cash from Investing -435.58
Cash from Financing 316.94
Net change in Cash 0.09
Free Cash Flow 258.48
Particulars MAR 2020 (Values in Cr)
Net Income 125.72
Cash from Operations 164.23
Cash from Investing -107.25
Cash from Financing -20.50
Net change in Cash 0.53
Free Cash Flow 270.26
Particulars MAR 2019 (Values in Cr)
Net Income 98.67
Cash from Operations 134.20
Cash from Investing -100.73
Cash from Financing -5.12
Net change in Cash 0.61
Free Cash Flow 212.20
Particulars MAR 2023 (Values in Cr)
Net Income 236.82
Cash from Operations 252.70
Cash from Investing -187.21
Cash from Financing -7.89
Net change in Cash -0.25
Free Cash Flow 490.15
Particulars MAR 2022 (Values in Cr)
Net Income 194.71
Cash from Operations 173.12
Cash from Investing -88.71
Cash from Financing -39.71
Net change in Cash -2.16
Free Cash Flow 324.93
Particulars MAR 2021 (Values in Cr)
Net Income 173.38
Cash from Operations 160.53
Cash from Investing -434.41
Cash from Financing 318.91
Net change in Cash 0.90
Free Cash Flow 254.49
Particulars MAR 2020 (Values in Cr)
Net Income 121.78
Cash from Operations 162.48
Cash from Investing -105.67
Cash from Financing -22.25
Net change in Cash -1.01
Free Cash Flow 266.90
Particulars MAR 2019 (Values in Cr)
Net Income 100.49
Cash from Operations 140.67
Cash from Investing -104.26
Cash from Financing -9.69
Net change in Cash -0.76
Free Cash Flow 188.36
Company Name Price P/E P/B Market Cap 52 Week Low/High
POLY MEDICURE LIMITED 1653.80 63.80 11.86 15871.75 945.00 / 1727.00
APOLLO HOSPITALS ENTER. L 5931.30 108.22 13.11 85282.99 4410.05 / 6871.30
FORTIS MALAR HOSPITALS LIMITED 72.93 0.00 2.30 136.68 44.00 / 107.94
SHREE PACETRONIX LTD. 215.15 19.94 6.91 77.44 121.60 / 391.90
TRANSGENE BIOTEK LTD. 6.47 0.00 4.41 49.02 3.57 / 12.46
Company Name Price P/E P/B Market Cap 52 Week Low/High
POLY MEDICURE LIMITED 1653.80 66.50 11.97 15871.75 945.00 / 1727.00
APOLLO HOSPITALS ENTER. L 5931.30 85.40 11.69 85282.99 4410.05 / 6871.30
Poly Medicure Ltd 1.40 0.84 0.13 0.49 0.00 / 0.00
CHENNAI MEENAKSHI MULTISPECIAL 34.43 95.64 144.24 25.72 19.50 / 54.65
KOVAI MEDICAL CENTER & HOSPITA 4022.10 27.83 5.63 4400.18 1968.15 / 4271.95

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 1650.70
  • 26 Days 1614.30
  • 10 Days 1645.80
  • 50 Days 1590.30
  • 12 Days 1644.40
  • 100 Days 1557.10
  • 20 Days 1622.90
  • 200 Days 1216.00
1682.28
PIVOT
First Resistance 1711.02
Second Resistance 1751.73
Third Resistance 1780.47
First Support 1641.57
Second Support 1612.83
Third Support 1572.12
RSI 60.84
MACD 30.08
Commodity Channel Index (CCI) 75.59
ADX 11.38
Williams % R -42.69

Over 1 Month

down

5.50

Over 3 Months

down

4.52

Over 6 Months

down

8.97

Over 1 Year

down

69.53

Over 3 Years

down

18.20

Over 5 Years

down

53.30

POLY MEDICURE LIMITED Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

POLY MEDICURE LIMITED Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Others
29.48
Promoter Holdings
53.14
FII
12.37
DII
4.99
Promoter Shares(Pledge Percentage)
0.0
Name Category Shares Shares%
Ezekiel Global Business Solutions Llp Public Shareholding 1.236132E7 12.88
Rishi Baid Shareholding of Promoter and Promoter Group 9766356.0 10.18
Zetta Matrix Consulting Llp Shareholding of Promoter and Promoter Group 8322160.0 8.67
Himanshu Baid Shareholding of Promoter and Promoter Group 7907624.0 8.24
Himanshu Baid (huf) Shareholding of Promoter and Promoter Group 3839200.0 4.0
Vcb Trading Llp Shareholding of Promoter and Promoter Group 3541144.0 3.69
Jai Polypan Pvt. Ltd. Shareholding of Promoter and Promoter Group 3352000.0 3.49
Smt.mukulika Baid Shareholding of Promoter and Promoter Group 3062400.0 3.19
Lighthouse India Iii Equity Investors Limited Public Shareholding 2826269.0 2.94
Rishi Baid (huf) Shareholding of Promoter and Promoter Group 2780000.0 2.9
Jugal Kishore Baid Shareholding of Promoter and Promoter Group 2279376.0 2.38
Smallcap World Fund, Inc Public Shareholding 2164847.0 2.26
Uti - Healthcare Fund Public Shareholding 2161255.0 2.25
Nirmala Vinodkumar Daga Public Shareholding 2087793.0 2.18
Quant Mutual Fund - Quant Consumption Fund Public Shareholding 2037997.0 2.12
Vishal Baid Shareholding of Promoter and Promoter Group 1681360.0 1.75
Varun Daga Public Shareholding 1558224.0 1.62
Shreans Daga Public Shareholding 1464845.0 1.53
Shaily Baid Shareholding of Promoter and Promoter Group 1188000.0 1.24
Shireen Baid Shareholding of Promoter and Promoter Group 1121600.0 1.17
Max Life Insurance Co. Ltd. - Pure Growth Fund Public Shareholding 1072433.0 1.12
Neha Baid Shareholding of Promoter and Promoter Group 1024000.0 1.07
Dhruv Baid Shareholding of Promoter and Promoter Group 360000.0 0.38
Arham Baid Shareholding of Promoter and Promoter Group 280000.0 0.29
Aaryaman Baid Shareholding of Promoter and Promoter Group 280000.0 0.29
Madhu Kothari Shareholding of Promoter and Promoter Group 151200.0 0.16
Vinay Kothari Shareholding of Promoter and Promoter Group 56000.0 0.06
Polycure Martech Limited Shareholding of Promoter and Promoter Group 10000.0 0.01
Bhupendra Raj Mehta Shareholding of Promoter and Promoter Group 1600.0 0.0

POLY MEDICURE LIMITED

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
2023-09-21 3.0 Final 2023-09-22 Equity shares 2022-09-16 2.5 Final 2022-09-19 Equity shares 2021-09-16 2.5 Final 2021-09-17 Equity shares 2020-02-27 2.0 Interim 2020-02-29 Equity shares 2019-09-13 2.0 Final 2019-09-17 Equity shares 2018-09-18 2.0 Final 2018-09-20 Equity shares 2017-09-20 0.5 Final 2017-09-22 Equity shares 2017-02-15 1.0 Interim 2 2017-02-16 Equity shares 2016-11-11 1.0 Interim 2016-11-15 Equity shares 2016-09-19 0.5 Final 2016-09-21 Equity shares 2016-03-17 2.5 Interim 2016-03-18 Equity shares 2015-09-18 2.5 Final 2015-09-22 Equity shares 2014-09-15 4.0 Final 2014-09-17 Equity shares 2013-09-19 2.0 Final 2013-09-23 Equity shares 2012-09-13 3.0 Final 2012-09-17 Equity shares 2011-08-25 3.0 Final 2011-08-27 Equity shares 2010-08-24 2.5 Final 2010-08-26 Equity shares 2009-08-21 2.5 Final 2009-08-25 Equity shares 2007-08-23 2.5 Final 2007-08-27 Equity shares 2005-09-06 0.0 Final 2005-09-09 Equity shares
Ex-Date Ex-Bonus Ratio
2017-03-28 2017-03-24 1:1 2013-07-10 2013-07-09 1:1 2010-03-29 2010-03-26 1:1
Ex-Date Old FV NEW FV Record Date
2015-02-02 10.0 5.0 2015-02-03

Learn More About Stocks

About POLY MEDICURE LIMITED

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by POLY MEDICURE LIMITED

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 5x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Poly Medicure Ltd?

Answer Field

The share price of Poly Medicure Ltd for NSE is ₹ 1671.25 and for BSE is ₹ 1647.2.

What is the Market Cap of Poly Medicure Ltd?

Answer Field

The market cap of Poly Medicure Ltd for NSE is ₹ 16,034.70 Cr. and for BSE is ₹ 15,803.95 Cr. as of now.

What is the 52 Week High and Low of Poly Medicure Ltd?

Answer Field

The 52 Week High and Low of Poly Medicure Ltd for NSE is ₹ 1729.00 and ₹ 945.00 and for BSE is ₹ 1727.00 and ₹ 945.00.

How to Buy Poly Medicure Ltd share?

Answer Field

You can trade in Poly Medicure Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Poly Medicure Ltd?

Answer Field

The 1 year returns on the stock has been 69.53%.

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

7 Lac+ Users

icon-with-text

4.3 App Rating

icon-with-text

4 Languages

icon-with-text

₹ 3800 Cr MTF Book

icon-with-text
loader